Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Argentine Patagonia: prevalence and clinical features of multiple sclerosis.
Melcon MO, Gold L, Carrá A, Cáceres F, Correale J, Cristiano E, Fernández Liguori N, Garcea O, Luetic G, Kremenchutzky M; Patagonia Multiple Sclerosis Research Project. Melcon MO, et al. Among authors: kremenchutzky m. Mult Scler. 2008 Jun;14(5):656-62. doi: 10.1177/1352458507085801. Mult Scler. 2008. PMID: 18566029
Further studies on HTLV-I associated myelopathy in Argentina.
Gonzalez LA, Villa AM, Kohler G, Garcea O, Kremenchutzky M, Caceres F, Sanz OP, Sica RE. Gonzalez LA, et al. Among authors: kremenchutzky m. Medicina (B Aires). 1998;58(4):411-4. Medicina (B Aires). 1998. PMID: 9816704
Anticipation of age at onset in familial multiple sclerosis.
Romero-Pinel L, Martínez-Yélamos S, Gubieras L, Matas E, Bau L, Kremenchutzky M, Arbizu T. Romero-Pinel L, et al. Among authors: kremenchutzky m. Eur J Neurol. 2010 Apr;17(4):572-5. doi: 10.1111/j.1468-1331.2009.02870.x. Epub 2009 Dec 7. Eur J Neurol. 2010. PMID: 20002735
Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: a randomized, placebo-controlled, multiple-dose study.
Lublin FD, Bowen JD, Huddlestone J, Kremenchutzky M, Carpenter A, Corboy JR, Freedman MS, Krupp L, Paulo C, Hariri RJ, Fischkoff SA. Lublin FD, et al. Among authors: kremenchutzky m. Mult Scler Relat Disord. 2014 Nov;3(6):696-704. doi: 10.1016/j.msard.2014.08.002. Epub 2014 Aug 29. Mult Scler Relat Disord. 2014. PMID: 25891548 Free article. Clinical Trial.
Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b.
Goodin DS, Reder AT, Traboulsee AL, Li DK, Langdon D, Cutter G, Cook S, O'Donnell T, Kremenchutzky M, Oger J, Koelbach R, Pohl C, Wicklein EM; IFNB Multiple Sclerosis Study Group and the 16- and 21-Year LTF Investigators. Goodin DS, et al. Among authors: kremenchutzky m. Mult Scler. 2019 May;25(6):837-847. doi: 10.1177/1352458518773511. Epub 2018 May 15. Mult Scler. 2019. PMID: 29761737
88 results